Aerovate Therapeutics Inc
- Stock Issuer and Owners
Aerovate Therapeutics Inc |
Ticker | AVTE |
CIK # | 0001798749 |
CUSIP | 008064107 |
Sector | Life Sciences - Pharmaceutical Preparations |
Address | 200 Berkeley Street Floor 18, Boston, MA 02116 |
Source |
[EDGAR]
|
Form 3/4/5 Filer |
2011 - 2024 |
Aerovate Therapeutics, Inc.
|
|
Santel Donald J
|
|
Katabi Maha
|
|
RA Capital Healthcare Fund LP
|
|
RA Capital Nexus Fund, L.P.
|
|
RA Capital Management LP
|
|
Shah Rajeev M.
|
|
Kolchinsky Peter
|
|
Dake Benjamin T
|
|
Dorval Allison
|
|
Iwicki Mark T
|
|
Resnick Joshua
|
|
Grayzel David S
|
|
Niven Ralph
|
|
Gillies Hunter
|
|
Verwijs Marinus
|
|
Noyes Timothy P
|
|
Pigot Timothy
|
|
Eldridge George A
|
|
Atlas Venture Fund XII, L.P.
|
|
Chen Bihua
|
|
Cormorant Global Healthcare Master Fund, LP
|
|
Cormorant Asset Management, LP
|
|
Cormorant Private Healthcare Fund II, LP
|
|
Atlas Venture Associates XII, L.P.
|
|
Atlas Venture Associates XII, LLC
|
|
Sofinnova Management X, L.P.
|
|
Sofinnova Venture Partners X, L.P.
|
|
Healy James
|
|
Form 13F Holdings |
Firm |
Period |
DFND |
Voting |
Shares |
RA Capital Management LP |
[2023-03-31]
|
SOLE |
0.0 |
8,263,982.0 |
Sofinnova Investments Inc |
[2023-03-31]
|
SOLE |
3,758,686.0 |
3,758,686.0 |
Atlas Venture Life Science Advisors LLC |
[2023-03-31]
|
SOLE |
2,039,249.0 |
2,039,249.0 |
Baker Bros Advisors LP |
[2023-03-31]
|
SOLE |
1,963,479.0 |
1,963,479.0 |
Cormorant Asset Management LP |
[2023-03-31]
|
DFND |
1,561,696.0 |
1,561,696.0 |
TCG Crossover Management LLC |
[2023-03-31]
|
SOLE |
1,081,274.0 |
1,081,274.0 |
VR Adviser LLC |
[2023-03-31]
|
SOLE |
833,927.0 |
833,927.0 |
OrbiMed Advisors LLC |
[2023-03-31]
|
DFND |
215,100.0 |
756,930.0 |
Great Point Partners LLC |
[2023-03-31]
|
DFND |
0.0 |
755,620.0 |
Octagon Capital Advisors LP |
[2023-03-31]
|
SOLE |
621,712.0 |
621,712.0 |
OUP Management Co LLC |
[2023-03-31]
|
SOLE |
603,762.0 |
603,762.0 |
BlackRock Inc. |
[2023-03-31]
|
SOLE |
587,175.0 |
599,999.0 |
FMR LLC |
[2023-03-31]
|
DFND |
570,180.0 |
570,965.0 |
Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
498,357.0 |
Frazier Life Sciences Management LP |
[2023-03-31]
|
SOLE |
338,110.0 |
338,110.0 |
Ghost Tree Capital LLC |
[2023-03-31]
|
SOLE |
200,000.0 |
200,000.0 |
Ikarian Capital LLC |
[2023-03-31]
|
SOLE |
195,146.0 |
195,146.0 |
Geode Capital Management LLC |
[2023-03-31]
|
DFND |
187,499.0 |
187,499.0 |
State Street Corp |
[2023-03-31]
|
DFND |
172,993.0 |
184,593.0 |
Fred Alger Management LLC |
[2023-03-31]
|
SOLE |
104,048.0 |
104,048.0 |
Nantahala Capital Management LLC |
[2023-03-31]
|
SOLE |
95,000.0 |
95,000.0 |
Northern Trust Corp |
[2023-03-31]
|
DFND |
798.0 |
77,439.0 |
Point72 Asset Management LP |
[2023-03-31]
|
DFND |
0.0 |
69,119.0 |
Skandinaviska Enskilda Banken AB (publ) |
[2023-03-31]
|
DFND |
0.0 |
50,866.0 |
Eversept Partners LP |
[2023-03-31]
|
SOLE |
50,242.0 |
50,242.0 |
Nan Fung Group Holdings Ltd |
[2023-03-31]
|
DFND |
47,936.0 |
47,936.0 |
Morgan Stanley |
[2023-03-31]
|
DFND |
44,794.0 |
44,974.0 |
Boothbay Fund Management LLC |
[2023-03-31]
|
OTR |
0.0 |
39,573.0 |
Nuveen Asset Management LLC |
[2023-03-31]
|
DFND |
36,310.0 |
36,310.0 |
Bank of New York Mellon Corp |
[2023-03-31]
|
DFND |
23,876.0 |
27,795.0 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 94575356, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
122854272